Cell and Gene therapy products

Articles containing or consisting of human cells or tissues that are intended for implantation, transplantation, infusion, or transfer to a human  recipient. Gene therapies are novel and complex products that can offer unique challenges in product development. Hence, ongoing communication between the FDA and stakeholders is essential to meet these challenges. Gene therapy products are being developed around the world, the FDA is engaged in a number of international harmonization activities in this area.

Examples: Musculoskeletal tissue, skin, ocular tissue, human heart valves; vascular graft, Dura mater, reproductive tissue/cells, Stem/progenitor cells ,somatic cells, Cells transduced with gene therapy vectors , Combination products (e.g., cells or tissue + device)

    Related Conference of Cell and Gene therapy products

    April 03-04, 2023

    International Conference on Aging and Gerontology

    Rome, Aland Islands
    May 03-04, 2023

    16th World Congress on Stem Cell Research

    Paris, France
    May 03-04, 2023

    Global Conference on Cell and Gene Therapy

    Paris, France
    June 08-09, 2023

    10th World Congress on Epigenetics and Chromosome

    Valencia, Spain
    August 21-22, 2023

    6th Annual Conference on Stem Cell and Regenerative Medicine

    Frankfurt, Germany
    September 25-26, 2023

    19th Global Summit on Stem Cell & Regenerative Medicine

    Zurich, Switzerland
    October 19-20, 2023

    5th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada
    December 07-08, 2023

    17th International Conference on Genomics & Pharmacogenomics

    San Francisco, USA

    Cell and Gene therapy products Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in